SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950168-97-000366
Filing Date
1997-02-14
Accepted
1997-02-14 00:00:00
Documents
1
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 SC 13G 5202
  Complete submission text file 0000950168-97-000366.txt   7003
Mailing Address
Business Address 3151 17TH STREET EXTENSION WILMINGTON NC 28401 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Subject) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 0930
Type: SC 13G | Act: 34 | File No.: 005-48083 | Film No.: 97535899
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address PPD INC 3151 17TH STREET EXTENSION WILMINGTON NC 28412
Business Address PPD INC 3151 17TH STREET EXTENSION WILMINGTON NC 28412 9102510081
ESHELMAN FREDRIC N (Filed by) CIK: 0001033409 (see all company filings)